Global Poultry Diagnostics Market is expected to reach USD 731.25 million by 2025 from USD 335.14 million in 2017, at a CAGR of 10.5% in the forecast period 2018 to 2025.
Access Full Report: http://databridgemarketresearch.com/reports/global-poultry-diagnostics-market/
Some of the major players operating in this market are IDEXX Laboratories, Inc., Zoetis, Thermo Fisher Scientific Inc., QIAGEN, Ubio Biotechnology Systems Pvt Ltd, Nisseiken Co.,Ltd, Gd Animal Health, DRG INSTRUMENTS GMBH, BIOINGENTECH BIOTECHNOLOGIES, INC., AffiniTech, LTD., BioNote, Inc., Idevt, Biochekk smart veterinary diagnostics among others.
UBIO BIOTECHNOLOGY SYSTEMS PVT LTD:
Founded in 2008 and headquartered in Kerala India. Ubio Biotechnology Systems Pvt Ltd is engaged in developing innovative solutions in medical, veterinary and food diagnostics. The company offers its products through various business profiles namely Medical IVD Test, Veterinary and Food Tests, Contract Manufacture, Contract Research, Diagnostics Manufacturing Equipment and others. They offer various product related to human diagnostics, veterinary diagnostics and IVD. Poultry diagnostics products are offered under veterinary diagnostics segment. Company’s product portfolio includes low-cost rapid tests for medical, veterinary and food diagnostics.
The company offers its product and services in various industries including software, pharmaceuticals and biotechnology industries and others.
It has certified R&D facility with international quality certification including GMP and ISO 13485. The company has strong presence in India.
THERMO FISHER SCIENTIFIC INC:
Founded in 2006 and headquartered in Massachusetts U.S. Thermo Fisher Scientific is engaged in providing instruments, equipment, reagents, consumables, software and services. The company operates in various business segments which include analytical instruments, life sciences solutions, specialty diagnostics, laboratory products & services. Poultry diagnostic products are offered under specialty diagnostics segment. The company offers its product and services in various industries including Pharma & Biotech, Academic & Government, Industrial & Applied and Diagnostics & Healthcare. The company is certified with international quality certifications which include ISO 9001:2008, ISO 9001:2013, ISO 13485 2003, ISO IEC 17025 2005 and others.
Some of its subsidiary are Patheon Inc. (Nethrlands), Dionex (U.S.), FEI Company (U.S.), Thermo Fisher Scientific (U.S.), Phadia9(Sweden), Affymetrix (U.S.), Nalge Nunc International (U.S.) and others. The company has its global presence in North America, Europe, Asia-Pacific and others
Founded in 1984 and headquartered at Hilden, Germany. Qiagen is engaged in sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company operates in 2 business segments namely, Consumables & related revenue and Instrumentation. The company offers its products through different product lines, namely Next-Gen Sequencing, Molecular Diagnostic, Life Science Research, Animal and Vet. Testing, Bioinformatics and others. Poultry diagnosis products fall under animal pathogens & genotyping consist of pathogen identification, animal genotyping and pyrosequencing.
Qiagen has its operations across the North America, Europe, Middle East and Africa, Asia-Pacific and rest of the world. Some of its subsidiaries include Exiqon (Denmark), Cellestis (Australia), Tiangen Biotech Co. Ltd. (Beijing), Qiagen Ltd. (India), Ipsogen SA (France) and other subsidiaries across the globe.
Global Poultry Diagnostics Market – Industry Trends and Forecast to 2027
North America Poultry Diagnostics Market – Industry Trends and Forecast to 2027
Europe Poultry Diagnostics Market – Industry Trends and Forecast to 2027
Asia-Pacific Poultry Diagnostic Market – Industry Trends and Forecast to 2027